[1]
2026. Assesment of prevalence of Metabolic Syndrome in Patients on Atypical Antipsychotics: A Cross-Sectional Study in Erode. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/6ch5fm78.